Skip to content

Smartphone Application for University Students With Binge Drinking Behavior

Smartphone Application for University Students With Binge Drinking Behavior: National Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06084832
Acronym
SmartBinge
Enrollment
628
Registered
2023-10-16
Start date
2023-10-01
Completion date
2026-07-31
Last updated
2025-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Drinking, Binge Drinking

Keywords

Alcohol, Binge Drinking, Phosphatidylethanol, Smartphone, Health

Brief summary

Alcohol use is a causal factor in more than 200 diseases and injury conditions (see ICD-10) and in France, alcohol is the first cause of hospitalization. Binge drinking (BD) has emerged as a major public health issue among student populations and is associated with negative consequences and social, cognitive and brain alterations. More than half of French university students have reported BD in the past month and are at increased risk of several alcohol-related consequences such as memory and sleep impairments, and reduced quality of life. BD is also a major risk factor in the development of alcohol addiction, with individual and environmental factors playing a role that is still poorly understood. Moreover, most students and young adults are reluctant to seek interventions when it is provided by health care professionals (only 4-5%) and have poor insight with regard to their alcohol use patterns / habits. Thus, there is an urgent need for developing effective prevention and intervention programs to reduce alcohol drinking in students. Recent studies have demonstrated that new types of technology-delivered interventions are promising tools for addressing unhealthy alcohol use. For example, an uncontrolled trial pilot study using a smartphone application-delivered intervention produced a reduction in both number of drinks per week and BD from baseline to 3-month follow-up. A recent review also showed significant outcomes of a mobile health intervention for self-control of unhealthy alcohol use. The investigators hypothesize that a timeline follow-back and personalized feedback based on the use of a mobile application can reduce excessive alcohol intake at 3-months. This study will provide scientific knowledge about BD in students, but also regarding a new type of intervention that could be effective for prevention in non-treatment seeking individuals and reducing the severity of health problems associated with excessive alcohol intake.

Interventions

BIOLOGICALblood microsampling

blood microsampling for the measure of Phosphatidylethanol

Sponsors

EPSM Marne, Reims
CollaboratorUNKNOWN
SCA-LAB UMR-CNRS 9193, Lille
CollaboratorUNKNOWN
Paul Valery University, Montpellier
CollaboratorUNKNOWN
Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

* Students between 18 and 25 years old * AUQ score greater than or equal to 24, and AUDIT score greater than or equal to 3 for its first 3 items. Drinking details with the DDQ when necessary. * BD behavior: at least one occasion with 6 or more drinks in the last 3 months. * Consent to be included in the study * Affiliated to social security

Exclusion criteria

* Not having a smartphone with an Apple or Android system. * Previous use of the MyDéfi smartphone application * Declaration of a psychiatric / neurologic condition * Pregnant, parturient or breastfeeding woman * Subject under guardianship, curators or restricted under public law

Design outcomes

Primary

MeasureTime frame
Change of the number of standard drinks per week30 months

Secondary

MeasureTime frameDescription
Change of the PEth concentration3 monthsphosphatidylethanol (PEth)

Countries

France

Contacts

Primary ContactMickael Naasila, Pr
mickael.naassila@u-picardie.fr03.22.82.76.72
Backup ContactSandra Bodeau, Dr
bodeau.sandra@chu-amiens.fr03.22.08.70.34

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026